HUMA.NASDAQHumacyte, INC
Form 4: Humacyte Director Exercises Stock Options
Sentiment:
SEC Form 4 Filing
Charles Bruce Green, a director at Humacyte, Inc., executed stock options to acquire 600 shares of common stock at $4.09 on May 17, 2024.
Summary
- On May 17, 2024, Charles Bruce Green, a director of Humacyte, Inc., exercised stock options.
- This transaction involved the acquisition of 600 shares of common stock at a price of $4.09 per share.
- Following the transaction, Mr. Green directly owns 12,400 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment.
Key Dates
| Date | Description |
|---|---|
| 09/15/2023 | Date stock options were exercisable |
| 05/17/2024 | Date of transaction: Stock options exercised |
| 05/20/2024 | Date of signature for the Form 4 filing |
| 09/15/2032 | Expiration date of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.